Iduronate-2-sulfatase

From WikiMD's WELLNESSPEDIA

Iduronate-2-sulfatase (I2S) is an enzyme that plays a crucial role in the lysosomes of animals, including humans. It is involved in the breakdown of glycosaminoglycans (GAGs), specifically dermatan sulfate and heparan sulfate.

Function[edit]

Iduronate-2-sulfatase is responsible for the hydrolysis of the 2-sulfate groups of the L-iduronate 2-sulfate units of dermatan sulfate and heparan sulfate. These complex molecules are broken down within lysosomes, the 'recycling centers' of cells, where they are degraded and their components are reused by the cell.

Clinical significance[edit]

Deficiency of I2S is associated with a rare genetic disorder known as Hunter syndrome (Mucopolysaccharidosis type II). This is an inherited condition in which the body is unable to break down certain complex molecules, leading to a range of symptoms including developmental delay, skeletal abnormalities, and organ enlargement.

Genetics[edit]

The gene that encodes I2S is located on the X chromosome, which means that Hunter syndrome is an X-linked recessive condition. This means that males are typically affected, while females are usually carriers of the condition.

Treatment[edit]

Treatment for Hunter syndrome involves managing the symptoms and improving quality of life. Enzyme replacement therapy, in which synthetic I2S is administered, can help to break down the accumulated GAGs and alleviate some of the symptoms.

See also[edit]

References[edit]

This article is a stub related to genetics. You can help WikiMD by expanding it!



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.